• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子与巨噬细胞分泌因子恶病质素的同一性。

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin.

作者信息

Beutler B, Greenwald D, Hulmes J D, Chang M, Pan Y C, Mathison J, Ulevitch R, Cerami A

出版信息

Nature. 1985;316(6028):552-4. doi: 10.1038/316552a0.

DOI:10.1038/316552a0
PMID:2993897
Abstract

In mammals, several well-defined metabolic changes occur during infection, many of which are attributable to products of the reticuloendothelial system. Among these changes, a hypertriglyceridaemic state is frequently evident, resulting from defective triglyceride clearance, caused by systemic suppression of the enzyme lipoprotein lipase (LPL). We have found previously that macrophages secrete the hormone cachectin, which specifically suppresses LPL activity in cultured adipocytes (3T3-L1 cells). When originally purified from RAW 264.7 (mouse macrophage) cells, cachectin was shown to have a pI of 4.7, a subunit size of relative molecular mass (Mr) 17,000 and to form non-covalent multimers. A receptor for cachectin was identified on non-tumorigenic cultured cells and on normal mouse liver membranes. A new high-yield purification technique has enabled us to determine further details of the structure of mouse cachectin. We now report that a high degree of homology exists between the N-terminal sequence of mouse cachectin and the N-terminal sequence recently determined for human tumour necrosis factor (TNF). Purified cachectin also possesses potent TNF activity in vitro. These findings suggest that the 'cachectin' and 'TNF' activities of murine macrophage conditioned medium are attributable to a single protein, which modulates the metabolic activities of normal as well as neoplastic cells through interaction with specific high-affinity receptors.

摘要

在哺乳动物中,感染期间会发生几种明确的代谢变化,其中许多变化归因于网状内皮系统的产物。在这些变化中,高甘油三酯血症状态经常很明显,这是由于脂蛋白脂肪酶(LPL)受到全身抑制导致甘油三酯清除缺陷所致。我们之前发现巨噬细胞分泌恶病质素,它能特异性抑制培养的脂肪细胞(3T3-L1细胞)中的LPL活性。最初从RAW 264.7(小鼠巨噬细胞)细胞中纯化出来时,恶病质素的pI为4.7,亚基大小为相对分子质量(Mr)17,000,并形成非共价多聚体。在非致瘤性培养细胞和正常小鼠肝细胞膜上鉴定出了恶病质素受体。一种新的高产纯化技术使我们能够进一步确定小鼠恶病质素的结构细节。我们现在报告,小鼠恶病质素的N端序列与最近确定的人肿瘤坏死因子(TNF)的N端序列存在高度同源性。纯化的恶病质素在体外也具有强大的TNF活性。这些发现表明,小鼠巨噬细胞条件培养基的“恶病质素”和“TNF”活性归因于一种单一蛋白质,该蛋白质通过与特定的高亲和力受体相互作用来调节正常细胞和肿瘤细胞的代谢活动。

相似文献

1
Identity of tumour necrosis factor and the macrophage-secreted factor cachectin.肿瘤坏死因子与巨噬细胞分泌因子恶病质素的同一性。
Nature. 1985;316(6028):552-4. doi: 10.1038/316552a0.
2
Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells.恶病质素的纯化,一种由内毒素诱导的RAW 264.7细胞分泌的脂蛋白脂肪酶抑制激素。
J Exp Med. 1985 May 1;161(5):984-95. doi: 10.1084/jem.161.5.984.
3
Regulation of lipoprotein lipase synthesis in 3T3-L1 adipocytes by cachectin. Further proof for identity with tumour necrosis factor.恶病质素对3T3-L1脂肪细胞中脂蛋白脂肪酶合成的调节。与肿瘤坏死因子一致性的进一步证据。
Biochem J. 1986 Dec 1;240(2):601-4. doi: 10.1042/bj2400601.
4
Cachectin/tumor necrosis factor and interleukin-1 show different modes of combined effect on lipoprotein lipase activity and intracellular lipolysis in 3T3-L1 cells.恶病质素/肿瘤坏死因子和白细胞介素-1对3T3-L1细胞中的脂蛋白脂肪酶活性和细胞内脂解作用显示出不同的联合效应模式。
Biochim Biophys Acta. 1989 Jun 8;1003(2):131-5. doi: 10.1016/0005-2760(89)90246-4.
5
Cachectin and tumour necrosis factor as two sides of the same biological coin.恶病质素与肿瘤坏死因子是同一枚生物硬币的两面。
Nature. 1986;320(6063):584-8. doi: 10.1038/320584a0.
6
Human recombinant TNF suppresses lipoprotein lipase activity and stimulates lipolysis in 3T3-L1 cells.人重组肿瘤坏死因子抑制3T3-L1细胞中的脂蛋白脂肪酶活性并刺激脂肪分解。
J Biochem. 1987 Feb;101(2):331-8. doi: 10.1093/oxfordjournals.jbchem.a121917.
7
Recombinant interleukin 1 suppresses lipoprotein lipase activity in 3T3-L1 cells.重组白细胞介素1抑制3T3-L1细胞中的脂蛋白脂肪酶活性。
J Immunol. 1985 Dec;135(6):3969-71.
8
Recombinant human cachectin/tumor necrosis factor but not interleukin-1 alpha downregulates lipoprotein lipase gene expression at the transcriptional level in mouse 3T3-L1 adipocytes.重组人恶病质素/肿瘤坏死因子而非白细胞介素-1α在转录水平下调小鼠3T3-L1脂肪细胞中脂蛋白脂肪酶基因的表达。
Mol Cell Biol. 1988 Jun;8(6):2394-401. doi: 10.1128/mcb.8.6.2394-2401.1988.
9
Suppression of lipoprotein lipase in 3T3-L1 cells by a mediator produced by SEKI melanoma, a cachexia-inducing human melanoma cell line.由SEKI黑色素瘤(一种可诱发恶病质的人类黑色素瘤细胞系)产生的介质对3T3-L1细胞中脂蛋白脂肪酶的抑制作用。
J Biochem. 1991 Jan;109(1):78-82.
10
Physiological responses to cachectin.对恶病质素的生理反应。
Ciba Found Symp. 1987;131:88-108. doi: 10.1002/9780470513521.ch7.

引用本文的文献

1
Circulating TNF-α levels in rheumatoid arthritis: a systematic review and meta-analysis and comparison to TNF-α levels in sepsis.类风湿关节炎中循环肿瘤坏死因子-α水平:一项系统评价与荟萃分析以及与脓毒症中肿瘤坏死因子-α水平的比较
Ther Adv Infect Dis. 2025 Sep 1;12:20499361251368006. doi: 10.1177/20499361251368006. eCollection 2025 Jan-Dec.
2
Regulation of hepatic Sirt1 expression and lipid metabolism through TNF receptor signaling.通过肿瘤坏死因子受体信号传导调节肝脏Sirt1表达和脂质代谢。
Front Immunol. 2025 Jul 22;16:1627433. doi: 10.3389/fimmu.2025.1627433. eCollection 2025.
3
Non-Coding RNAs in Regulating Fat Deposition in Farm Animals.
非编码RNA对家畜脂肪沉积的调控
Animals (Basel). 2025 Mar 11;15(6):797. doi: 10.3390/ani15060797.
4
Understanding cachexia and its impact on lung cancer and beyond.了解恶病质及其对肺癌及其他方面的影响。
Chin Med J Pulm Crit Care Med. 2024 Mar 20;2(2):95-105. doi: 10.1016/j.pccm.2024.02.003. eCollection 2024 Jun.
5
Targeting cytokine and chemokine signaling pathways for cancer therapy.针对细胞因子和趋化因子信号通路的癌症治疗。
Signal Transduct Target Ther. 2024 Jul 22;9(1):176. doi: 10.1038/s41392-024-01868-3.
6
Obesity, dyslipidemia, and cardiovascular disease: A joint expert review from the Obesity Medicine Association and the National Lipid Association 2024.肥胖、血脂异常与心血管疾病:肥胖医学协会和国家脂质协会2024年联合专家综述
Obes Pillars. 2024 Mar 12;10:100108. doi: 10.1016/j.obpill.2024.100108. eCollection 2024 Jun.
7
TNF in Human Tuberculosis: A Double-Edged Sword.肿瘤坏死因子在人类结核病中的作用:一把双刃剑
Immune Netw. 2024 Jan 26;24(1):e4. doi: 10.4110/in.2024.24.e4. eCollection 2024 Feb.
8
Recent Advances and Challenges in the Early Diagnosis and Treatment of Preterm Labor.早产的早期诊断与治疗的最新进展和挑战
Bioengineering (Basel). 2024 Feb 6;11(2):161. doi: 10.3390/bioengineering11020161.
9
Oral TNF-α siRNA delivery via milk-derived exosomes for effective treatment of inflammatory bowel disease.通过源自牛奶的外泌体进行口服肿瘤坏死因子-α小干扰RNA递送以有效治疗炎症性肠病。
Bioact Mater. 2023 Dec 22;34:138-149. doi: 10.1016/j.bioactmat.2023.12.010. eCollection 2024 Apr.
10
Macrophage and T cell networks in adipose tissue.脂肪组织中的巨噬细胞和 T 细胞网络。
Nat Rev Endocrinol. 2024 Jan;20(1):50-61. doi: 10.1038/s41574-023-00908-2. Epub 2023 Oct 23.